[1]Locationinpatent:experimentalpartFlanagan,MarkE.;Blumenkopf,ToddA.;Brissette,WilliamH.;Brown,MatthewF.;Casavant,JeffreyM.;Shang-Poa,Chang;Doty,JonathanL.;Elliott,EileenA.;Fisher,MichaelB.;Hines,Michael;Kent,Craig;Kudlacz,ElizabethM.;Lillie,BrettM.;Magnuson,KellyS.;McCurdy,SandraP.;Munchhof,MichaelJ.;Perry,BretD.;Sawyer,PerryS.;Strelevitz,TimothyJ.;Subramanyam,Chakrapani;Sun,Jianmin;Whipple,DavidA.;Changelian,PaulS.[JournalofMedicinalChemistry,2010,vol.53,#24,p.8468-8484]
[1]CurrentPatentAssignee:MSNLABORATORIESPRIVATELIMITED;SAMSUNGELECTRONICSCO.,LTD.-US2016/122354,2016,A1
[2]CurrentPatentAssignee:SHANDONGUNIVERSITY-CN106146517,2016,A
[3]CurrentPatentAssignee:YANGTZERIVERPHARMACEUTICALGROUPCOLTD-CN107793418,2018,A
[4]CurrentPatentAssignee:LEADINGPHARMMEDICALTECH-CN109776547,2019,A
Title: Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitors.
Journal: Journal of medicinal chemistry 20120628